Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
about
Novel therapeutic strategies targeting HIV integraseDolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kineticsStructural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding InhibitorMechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation InhibitorsPharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor.Resistance to integrase inhibitors.Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance.Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance.The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug ResistanceNatural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitorsHIV Drug Resistance and the Advent of Integrase Inhibitors.Dolutegravir (S/GSK1349572) exhibits significantly slower dissociation than raltegravir and elvitegravir from wild-type and integrase inhibitor-resistant HIV-1 integrase-DNA complexes.Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.Inhibiting the HIV integration process: past, present, and the future.Raltegravir flexibility and its impact on recognition by the HIV-1 IN targets.Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors.
P2860
Q27003960-99CA8DA9-5745-44B2-8343-A769BC969BDFQ28534464-55BDA7FD-A6DA-42DD-8D72-2FF0B9C78CAAQ28547968-C0AF16B5-E564-4804-9DE9-855EF660A03FQ28554482-EB29C4C7-6D41-4D2E-AD40-E68132E4A103Q33911400-EDA5A07B-8317-4A00-A939-4FC365D5C293Q34059896-740C148C-BC78-457E-892E-CED8E9C7D60CQ34136227-3BBBF5EA-EA58-4453-925C-E055E730663FQ34245624-0572F57B-5834-456A-BC64-61BDBB16E728Q34937254-7AEAC3A6-4748-443A-8C78-062AACD47520Q37288671-D6825C18-14BF-4504-95B7-64ACDEDCE0A2Q37392831-CA86AE06-AE3D-40D1-9419-D2EDFD8C03A7Q38062462-EE32455B-3B92-489F-AF21-3BE6FE6ED00FQ38627271-B34F5604-31E0-4AD3-9AE2-AF6BD62D4D28Q38924027-B798F21B-D7B9-4BFC-9298-E56CA74E5C91Q39352071-76F383F5-12E6-4ACC-90BC-127AC2500DCAQ42285229-682BCD89-C8D3-46F2-84C4-C9F26C090529Q45745977-BF6867E4-18DC-40E5-9840-C8158DA55BE5
P2860
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@ast
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@en
type
label
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@ast
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@en
prefLabel
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@ast
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@en
P2093
P2860
P356
P1476
Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.
@en
P2093
Brian Terry
Himadri K Samanta
Ira B Dicker
Mark R Krystal
Michael A Walker
Sagarika Bollini
Volodymyr Gali
Zhufang Li
P2860
P304
23599-23609
P356
10.1074/JBC.M804213200
P407
P577
2008-06-24T00:00:00Z